Kabiven®, Kabiven® Peripheral

(amino acids, electrolytes, glucose, lipid emulsion)

For GB healthcare professionals only. This content contains promotional and brand information.
 
Scroll down for prescribing information for multi-chamber bag products and further product information. Adverse event reporting details are available at the bottom of this webpage.

For more product information and resources for Fresenius Kabi's multi-chamber bags, visit: multichamberbags.co.uk
 
Multi-chamber bags for parenteral nutrition for patients and children above 2 years of age when oral or enteral nutrition is impossible, insufficient, or contraindicated.
 
PN should be monitored, and doses adjusted according to individual patient response. Please refer to the Summary of Product Characteristics before prescribing.

Please note product image is for illustrative purposes only and labelling on actual product may appear differently.
 
Filename
Multi-Chamber Bag Prescribing Information.pdf
Size
167 KB
Format
pdf
Multi-Chamber Bag Prescribing Information.pdf
Filename
Macronutrient Prescribing Information.pdf
Size
209 KB
Format
pdf
Macronutrient Prescribing Information.pdf

Details

 
  • Several bag sizes to meet varying patient requirements
  • Contain Intralipid 20%® (soya-bean oil) - see macronutrient prescribing information in the link above
  • Shelf life of these products (unmixed in the overpouch): 2 years
 

 

  • Three chamber bag 
  • Kabiven is for central venous administration only
  • Kabiven Peripheral may be infused into a peripheral or central vein. 

Kabiven and Kabiven Peripheral: Parenteral nutrition for patients and children above two years of age, when oral or enteral nutrition is impossible, insufficient or contraindicated.

Kabiven®
Item descriptionUnit sizeCase qtyOrder code 
Kabiven® 14gN2566ml3831223220
Kabiven® 11gN2053ml4831222221
Kabiven® 8gN1540ml4831221220
Kabiven® Peripheral 9gN2400ml3831233220
Kabiven® Peripheral 7gN1920ml4831232220
Kabiven® Peripheral 5gN1440ml4831231220

gN = grams of nitrogen


Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk  Adverse events should also be reported to Fresenius Kabi Limited.  Email: Pharmacovigilance.GB@fresenius-kabi.com

 

GB-Kab-2400001 January 2025

By entering the Healthcare Professional Area you are confirming you are a GB Healthcare Professional. This area contains promotional information. If you are not a Healthcare Professional you will be directed to the Fresenius Kabi GB Corporate website.

GB-NP-2400163 October 2024